Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.

NCT02405910 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI Left Institution

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

West Virginia University

Collaborators

[object Object]